Abstract
Erysipelas is a superficial cutaneous process that is usually restricted to the dermis, but with prominent lymphatic involvement commonly caused by streptococci. We present a patient who was admitted for swelling and erythema of his left cheek. We diagnosed facial erysipelas, the curative treatment was based on the prescription of effective antibiotic therapy against streptococci and bacteria producing β-lactamase (staphylococci). Removal of the remaining teeth was scheduled during medical treatment. At a 4-month follow-up after dental removal, there has been no recurrence of erysipelas.
Through a clinical case of facial erysipelas, this work allows illustrating the specificities of this pathology.
References
Bläckberg A, Trell K, Rasmussen M. Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infect Dis. 2015 ;15:402–7.6. https://doi.org/10.1186/s12879-015-1134-2
Morris AD. Cellulitis and erysipelas. BMJ Clin Evid. 2008:1708–15.
Bonnetblanc JM, Bédane C. Erysipelas, recognition and management. Am J Clin Dermatol. 2003;4(3):157-63. https://doi.org/10.2165/00128071-200304030-00002
Michael Y, Shaukat NM. Erysipelas. StatPearls Publishing; Jan 2020 :1-9.
Stevens DL, Bryant AE. Impetigo, Erysipelas and Cellulitis. Streptococcus pyogenes.
Ferretti JJ, Stevens DL, Fischetti VA. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center. Feb 10 2016 :1-27
Blum C-L, Menzinger S, Genné D. Erysipèle : manifestations cliniques et prise en charge. Rev Med Suisse. 2013; 9 : 1812-5. [2020 Dec 01]. Available from: https://www.revmed.ch/view/483942/4024689/RMS_idPAS_D_ISBN_pu2013-34s_sa03_art03.pdf
Zürcher S, Toutous L Trellu Erysipèle et dermohypodermite récidivants : prise en charge Rev Med Suisse 2015 ; 11 : 759-62.
Lipsky BA, Moran GJ, Napolitano LM, Vo L, Nicholson S, Kin M. A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: Clinical characteristics, medical treatment, and outcomes. BMC Infect Dis 2012 ;12(227) :1-11. https://doi.org/10.1186/1471-2334-12-227
Bonnetblanc JM, Bédane C Erysipelas Recognition and Management. Am J Clin Dermatol. 2003;4(3):157-63. https://doi.org/10.2165/00128071-200304030-00002
Caetano M, Amorim I Erysipela. Acta Med Port. Sep-Oct 2005;18(5):385-93.
Pigatto PD, Brambilla L, Guzzi G. Erysipelas-like mercury exanthem related to dental metal allergy. J Plastic Dermat. 2011;7(3):275-7.
Titou H, Ebongo C, Bouati E, Boui M Risk factors associated with local complications of erysipelas: a retrospective study of 152 cases. Pan African Med J. 2017; 26(66):1-7. https://doi.org/10.11604/pamj.2017.26.66.11096
Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005; 41:1373-406. https://doi.org/10.1086/497143
Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim EG, McDougal KL, Carey BR, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006 ; 355: 666-74. https://doi.org/10.1056/nejmoa055356
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52. https://doi.org/10.1093/cid/ciu444
Dall L, Peterson S, Simmons T, Dall A. Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy. Cutis. 2005 Mar;75(3):177-80.
Celestin R, Brown J, Kihiczak G, Schwartz RA. Erysipelas: a common potentially dangerous infection. Acta Dermatovenerol Alp Pannonica Adriat. 2007 Sep;16(3):123-7.
Krasagakis K, Samonis G, Valachis A, Maniatakis P, Evangelou G, Tosca A. Local complications of erysipelas: a study of associated risk factors. Clin Exp Dermatol. 2011 ;36(4):351-354. https://doi.org/10.1111/j.1365-2230.2010.03978.x
Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD009758.. https://doi.org/10.1002/14651858.cd009758.pub2
Radakovic S, Holzer G, Tanew A. Erysipelas-like erythema as a cutaneous sign of familial Mediterranean fever: A case report and review of the histopathologic findings. J am acad dermatol. 2012 ;68(2) :61-63. https://doi.org/10.1016/j.jaad.2012.09.038
Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: A Review of Our Current Understanding. Am J Clin Dermatol. 2016 Jun;17(3):277-92. https://doi.org/10.1007/s40257-016-0186-4
Davido N, Barère F, Yasukawa K. Cellulites faciales odontogènes de l’adulte Prise en charge médico-chirurgicale. l’information dentaire. 2011 ; (25) :75-82
Brown SJ. Atopic Eczema. Clin Med (Lond). 2016 Feb;16(1):66-9. https://doi.org/10.7861/clinmedicine.16-1-66
Ouattara B, Bissa H, Djieukam MC, Fokui Jules V, Diolande GF, Kouadio L. Les thrombophlebites en stomatologie et chirurgie maxillo-faciale. Rev. Iv. Odonto-Stomatol. 2010 ;12(1) :12-15
Oh CC, Ko HC, Lee HY, Safdar N, Maki DG, Chlebicki MP. Antibiotic prophylaxis for preventing recurrent cellulitis: A systematic review and meta-analysis. J Infect. 2014 Jul;69(1):26-34. https://doi.org/10.1016/j.jinf.2014.02.011
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Hallab L & Taleb B
